Northern Trust Corp Nuvalent, Inc. Transaction History

Northern Trust Corp

$600 Billion
Q3 2024

A detailed history of Northern Trust Corp transactions in Nuvalent, Inc. stock. As of the latest transaction made, Northern Trust Corp holds 319,780 shares of NUVL stock, worth $30.1 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

319,780

Previous 264,710 20.8%

Holding current value

$30.1 Million

Previous $20.1 Million 62.91%

% of portfolio

0.01%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$67.44 - $112.17 $3.71 Million - $6.18 Million	55,070 Added 20.8%	319,780 $32.7 Million
Q2 2024 Aug 14, 2024	SELL	$62.76 - $81.61 $154,075 - $200,352	-2,455 Reduced 0.92%	264,710 $20.1 Million
Q1 2024 May 14, 2024	SELL	$72.35 - $88.99 $969,924 - $1.19 Million	-13,406 Reduced 4.78%	267,165 $20.1 Million
Q4 2023 Feb 13, 2024	BUY	$42.42 - $80.28 $1.42 Million - $2.69 Million	33,465 Added 13.54%	280,571 $20.6 Million
Q3 2023 Nov 13, 2023	BUY	$39.12 - $49.85 $76,362 - $97,307	1,952 Added 0.8%	247,106 $11.4 Million
Q2 2023 Aug 11, 2023	BUY	$23.58 - $44.68 $1.6 Million - $3.04 Million	68,062 Added 38.43%	245,154 $10.3 Million
Q1 2023 May 15, 2023	SELL	$25.42 - $33.52 $30,554 - $40,291	-1,202 Reduced 0.67%	177,092 $4.62 Million
Q4 2022 Feb 13, 2023	BUY	$18.46 - $36.37 $711,005 - $1.4 Million	38,516 Added 27.56%	178,294 $5.31 Million
Q3 2022 Nov 14, 2022	BUY	$13.55 - $19.92 $165,201 - $242,864	12,192 Added 9.56%	139,778 $2.72 Million
Q2 2022 Aug 12, 2022	SELL	$7.4 - $15.07 $88,689 - $180,613	-11,985 Reduced 8.59%	127,586 $1.73 Million
Q1 2022 May 13, 2022	BUY	$11.65 - $19.57 $478,512 - $803,818	41,074 Added 41.7%	139,571 $1.94 Million
Q4 2021 Feb 08, 2022	BUY	$18.01 - $30.1 $84,809 - $141,740	4,709 Added 5.02%	98,497 $1.88 Million
Q3 2021 Nov 15, 2021	BUY	$18.25 - $38.35 $1.71 Million - $3.6 Million	93,788 New	93,788 $2.12 Million

Others Institutions Holding NUVL

# of Institutions

210

Shares Held

59.5M

Call Options Held

450K

Put Options Held

619K

View Full List

About Nuvalent, Inc.

Ticker NUVL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,977,800
Market Cap $4.05B
Description
Nuvalent, Inc., a clinical stage biopharmaceutical company, develops therapies for patients with cancer. Its lead product candidates are NVL-520, a brain-penetrant ROS1-selective inhibitor to inhibit ROS1 fusions that express the normal ROS1 kinase domain without any drug-resistant mutations and remain active in the presence of mutations conferr...

More about NUVL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.

Account

Northern Trust Corp Nuvalent, Inc. Transaction History